Report
Onward Medical FIRST LOOK: MJ Fox and US DoD back further development in Parkinson's
Onward received grants from the Michael J. Fox Foundation ($1m) and the US Department of Defense ($1.5m) to study its ARC-IM system in Parkinson's disease. With these grants, the company aims to set up clinical feasibility studies to assess both mobility (n=56) and blood pressure instability (n=5) in Parkinson's patients. The move into Parkinson's follows an earlier case study, and could become a second pillar for Onward if positive results can be confirmed. € 10.4 TP and Buy rating reiterated.
Underlying
ONWARD MEDICAL NV
Provider
KBC Securities
We are a financial services provider for several types of professional clients, each with distinct needs.
Thomas Vranken
Other Reports on these Companies
Other Reports from KBC Securities
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.